HY-D0090-100mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
HY-D0090-200mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
HY-D0090-50mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
HY-D0090-500mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
HY-D0815-10mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-100mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-5mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-50mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-500mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-116215-1mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-10mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-100mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-25mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-5mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-50mg
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6]
|
|
|
|
HY-116215-1mL
|
MedChemexpress LLC
|
2-NBDG [CAS 186689-07-6] (10mM in DMSO)
|
|
|
|
HY-153231-500ug
|
MedChemexpress LLC
|
eGFP mRNA-LNP
|
|
|
|
HY-150724B-1mg
|
MedChemexpress LLC
|
FITC-labeled ODN 1018 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-150724B-10mg
|
MedChemexpress LLC
|
FITC-labeled ODN 1018 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-150724B-5mg
|
MedChemexpress LLC
|
FITC-labeled ODN 1018 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-150741B-1mg
|
MedChemexpress LLC
|
FITC-labeled ODN 2216 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-150741B-5mg
|
MedChemexpress LLC
|
FITC-labeled ODN 2216 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-111330-1mg
|
MedChemexpress LLC
|
Hydroxyphenyl Fluorescein [CAS 359010-69-8]
|
|
Metabolism-sugar/lipid metabolism
|
|